Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Quest Diagnostics Inc. buy SVB Leerink LLC

Start price
€146.55
06.01.25 / 50%
Target price
€166.95
06.01.26
Performance (%)
4.71%
End price
€153.45
07.01.26
Summary
This prediction ended on 07.01.26 with a price of €153.45. The BUY prediction by SVB_Leerink_LLC finished with a performance of 4.71%. SVB_Leerink_LLC has a follow-up prediction for Quest Diagnostics Inc. where he still thinks Quest Diagnostics Inc. is a Buy. Dividends of €0.73 are taken into consideration when calculating the performance. SVB_Leerink_LLC has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Quest Diagnostics Inc. -1.616% -1.616% 9.616%
iShares Core DAX® -1.673% 2.237% 16.344%
iShares Nasdaq 100 -1.346% 0.290% 3.851%
iShares Nikkei 225® -1.529% 5.863% 18.286%
iShares S&P 500 -1.702% 0.697% 1.755%

Comments by SVB_Leerink_LLC for this prediction

In the thread Quest Diagnostics Inc. diskutieren
Prediction Buy
Perf. (%) 4.71%
Target price 166.953
Change
Ends at 06.01.26

Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $174.00 price target on the stock, up previously from $169.00.
Ratings data for DGX provided by MarketBeat

In the thread Trading Quest Diagnostics Inc.
Prediction Buy
Perf. (%) 4.71%
Target price 166.953
Change
Ends at 06.01.26

Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten

Current prediction by SVB_Leerink_LLC for Quest Diagnostics Inc.

buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€159.15
21.10.25
-
21.10.26
-3.24%
15:47